Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

Doctors stuck at imaging crossroads have new tool to guide CAD decision-making

A new AI methodology can help determine if stress testing or CCTA should be used to assess patients with chest pain—a common precursor to coronary artery disease.

Thumbnail

Catheter ablation tops medication alone for treating AFib—but the risk of complications remains

Catheter ablation is associated with better outcomes for AFib patients, researchers noted, but beginning treatment with just antiarrhythmic medications may be the most practical option. 

SCAI 2021: COVID-19 especially harmful for high-risk heart attack patients

Researchers presented new data from the North American COVID-19 Myocardial Infarction registry, detailing the ongoing pandemic's "deadly impact." 

Thumbnail

SCAI unveils new cath lab guidelines at annual meeting

The new guidelines were endorsed by the American College of Cardiology, American Heart Association, Heart Rhythm Society and Clinical Policy Approval Committee.

Early CMR imaging improves diagnosis of unexplained heart attacks

Turning to the modality just a few days earlier appeared to make a significant impact when it came to making an accurate diagnosis. 

Humana

Humana agrees to take second look at panned payment change labeling PET/CT as ‘investigational’

The American Society of Nuclear Cardiology recently met with the Louisville, Kentucky, insurer, which shared an openness to reviewing a recent coverage determination. 

Thumbnail

AI uses ECG, X-ray data to improve treatment of arrhythmic disorders

An international group of researchers developed a deep learning model capable of identifying accessory pathways in patients with Wolff-Parkinson-White syndrome.

Thumbnail

Transseptal MViV for high-risk patients associated with 100% success rate after 1 year

Researchers explored data from one arm of the MITRAL early feasible study, sharing their findings in JACC: Cardiovascular Interventions.